Nanostics
Business Services · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
10155 102 St NW, Edmonton, Alberta, T5J ...Phone Number
(800) 672-2027Website
www.nanosticsdx.comRevenue
<$5 MillionIndustry
About Nanostics
Nanostics Precision Health is a commercial-stage precision health company focused on developing innovative, non-invasive diagnostic tests aimed at early detection and management of cancers, as well as cardiovascular and neurodegenerative diseases. Their flagship product, ClarityDX Prostate, utilizes clinical features and blood-based biomarkers to assess the risk of aggressive prostate cancer, enhancing the decision-making process for patients and healthcare providers. The company aims to reduce unnecessary invasive procedures like prostate biopsies through improved prediction capabilities. Nanostics collaborates with various partners and continues to evolve its offerings to support better healthcare outcomes.Explore more
Nanostics Org Chart
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Compare Similar Companies to Nanostics
Compare insights from companies similar to Nanostics, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
Nanostics Tech Stack
A closer look at the technologies used by Nanostics
Top Business Services Companies
Frequently Asked Questions Regarding Nanostics
Sign Up For FreeTo access detailed company insights
Nanostics Precision Health is a commercial-stage precision health company focused on developing innovative, non-invasive diagnostic tests aimed at early detection and management of cancers, as well as cardiovascular and neurodegenerative diseases. Their flagship product, ClarityDX Prostate, utilizes clinical features and blood-based biomarkers to a... Read More
